• If you enjoy the forum please consider supporting it by signing up for a NES Membership  The benefits pay for the membership many times over.

CURE found for covid long haul, CFS (chronic fatigue syndrome) &c, possibly PTSD, scleroderma

Status
Not open for further replies.
Subject, stalling syndrome Should obtain 1350 mg, single dose/Patient, of B7 aptamer from Berlin Cures and Start Stateside Clinical Phase Studies ASAP- as it is found to be Cure for covid long haul & CFS (chronic fatigue syndrome)

PART II
Joseph W Arabasz MD
https://www.berlincures.com/en/bc- 7-pipeline

BC 7 currently still in development and needs to get approval​

The goal of Berlin Cures, is to make BC7 available on the market as fast as ever possible for LCS-patients and, in parallel, to successfully complete all clinical studies
Currently, Berlin Cures is getting the Lab prepared for study-related analytic tests. Therefore, effective immediately, Berlin Cures will no longer accept incoming specimens for the measurement of autoantibodies. Please do NOT send us specimens. Thank you for your understanding.

https://www.berlincures.com/en/bc-7-pipeline

Berlin Cures

https://www.berlincures.com/en/bc- 7-pipeline

Long Covid Syndrome (LCS)

Depending on the source, it is assumed that about 10 to 30% of all patients infected with Corona virus suffer from Long Covid Syndrome (LCS) in varying degrees. Wallukat (Wallukat G et al., 2021) demonstrated that more than 90% of patients with LCS have autoantibodies against G protein-coupled receptors.In four patients treated with BC 7 under compassionate use conditions at the University of Erlangen with the intention to neutralize these autoantibodies, an enormous remission of LCS could be achieved in a short time, so that one could speak of a cure.

This astounding result triggered an enormous international media response. In fact, BC 007 appears to be the only drug worldwide that may help cure LCS.

At the moment, Berlin Cures is – with utmost efforts – in the process of preparing a two-arm, double-blind, placebo-controlled clinical trial (RCT) to demonstrate the efficacy of BC 7 in a large number of patients with LCS.

Regulator’s feedback
The study design will be submitted to the relevant regulatory authorities for review in Q1 2022. Berlin Cures expects to receive the regulator’s feedback in 2022 on how to further proceed with our clinical studies. The main goal of Berlin Cures is to make BC 007 available on the market for LCS patients as fast as possible. The vast number of LCS patients worldwide clearly substantiates that the demand and the market potential for BC 007 for the treatment of LCS is enormous. For updated info please consult the News Section.
LATEST UPDATES

BC 7 appears to be the only drug worldwide that may help cure LCS.
INFORMATION FOR LCS PATIENTS

Long CovidSyndrome (LCS)
Depending on the source, it is assumed that about 10 to 30% of all patients infected with Corona virus suffer from Long Covid Syndrome (LCS) in varying degrees. Wallukat (Wallukat G et al., 2021) demonstrated that more than 90% of patients with LCS have autoantibodies against G protein-coupled receptors.

In four patients treated with BC 007 under compassionate use conditions at the University of Erlangen with the intention to neutralize these autoantibodies, an enormous remission of LCS could be achieved in a short time, so that one could speak of a cure.

This astounding result triggered an enormous international media response. In fact, BC 007 appears to be the only drug worldwide that may help cure LCS.
At the moment, Berlin Cures is – with utmost efforts – in the process of preparing a two-arm, double-blind, placebo-controlled clinical trial (RCT) to demonstrate the efficacy of BC 007 in a large number of patients with LCS.

Regulator’s feedback
The study design will be submitted to the relevant regulatory authorities for review in Q1 2022. Berlin Cures expects to receive the regulator’s feedback in 2022 on how to further proceed with our clinical studies. The main goal of Berlin Cures is to make BC 007 available on the market for LCS patients as fast as possible. The vast number of LCS patients worldwide clearly substantiates that the demand and the market potential for BC 007 for the treatment of LCS is enormous. For updated info please consult the News Section.


LATEST UPDATES
News & Press – Berlin Cures
BC 007 appears to be the only drug worldwide that may help cure LCS

nice spam, but still....


View: https://www.youtube.com/watch?v=Zd8vzIRQLLM
 
Status
Not open for further replies.
Back
Top Bottom